Defining and targeting cardiac lipid dysregulation in Friedreich ataxia using human iPSC-derived cardiac models
AIMs_Play: Predicting Disease Progression in Pediatric Friedreich Ataxia with Generative AI-Enabled Platform
Neuro-otology: Diffusion MRI and audiological biomarkers for Friedreich ataxia disease progression
Characterization of Fatigue in Patients with Friedreich’s Ataxia by Assessment of Mitochondrial Function in Skeletal and Cardiac Muscle
Leveraging Real-World Data to Define Clinical Milestones and Assess Pharmacologic Impact in Friedreich’s Ataxia Progression
Enhancing Friedreich Ataxia Research: Data Augmentation and Multimodal Fusion Focusing on the Spine-Brain Axis
Quantifying sitting balance in children and adults with Friedreich ataxia – development of clinical and instrumented measures
Mitochondrial Enzyme Activity and Biomarker Evaluation in FA Treatment (MEABET-FA)
Deriving Functional MRI Equivalent Biomarkers in Friedreich Ataxia solely using Brain Structure Data
Multimodal peripheral nervous system imaging to quantify, monitor, and understand the neuropathy of Friedreich ataxia
Elucidation of the peripheral immune axis in FRDA and identification of blood-based biomarkers of inflammation
Measurement of Frataxin mRNA in NHP and human biofluids